1. Present infomration about current understanding of checkpoint inhibitors and current use of immune checkpoint inhibitor (ICI) therapy.
2. Discuss current literature about rheumatologic immune-related adverse events (irAEs) via various retrospective case series.
3. Propose some initiatives for further investigation and future research related to Rheumatologic irAEs.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation